Jpmorgan Chase & CO Genprex, Inc. Transaction History

Jpmorgan Chase & CO

  • $1.22 Trillion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024
BUY
$0.19 - $0.37 $6 - $13
36 Added 15.32%
271 $0
Q3 2023

Nov 14, 2023
BUY
$0.37 - $1.04 $21 - $60
58 Added 32.77%
235 $0
Q3 2021

Nov 12, 2021
BUY
$2.59 - $3.36 $458 - $594
177 New
177 $0

Others Institutions Holding GNPX

# of Institutions
2
Shares Held
600
Call Options Held
0
Put Options Held
0
View Full List

About Genprex, Inc.

GNPX Quotes by TradingView
  • Ticker GNPX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,020,300
  • Market Cap $76.8M
  • Description
  • Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incor...
More about GNPX
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email